In the global medical and beauty supply chain, leading brands must conduct rigorous raw material audits to prevent deep-tissue contamination. Because micro-needles penetrate past the stratum corneum, the metallic alloy matrix must be entirely free from heavy metal trace impurities such as lead, nickel, and cadmium.

To guarantee compliance, advanced manufacturing facilities utilize Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to screen raw steel wire down to parts-per-billion (ppb) detection thresholds.

Following mass spectrometry clearance, completed needle assemblies must undergo strict biological screening in accordance with ISO 10993-5 (In Vitro Cytotoxicity testing). By exposing mammalian cell cultures directly to needle extract fluids, engineers can verify that the material does not induce adverse cellular reactions or toxicity. This comprehensive verification protocol protects global aesthetic distribution networks from regulatory recalls and ensures total structural biocompatibility.